426 related articles for article (PubMed ID: 18852287)
21. Regulation of AKT1 expression by beta-catenin/Tcf/Lef signaling in colorectal cancer cells.
Dihlmann S; Kloor M; Fallsehr C; von Knebel Doeberitz M
Carcinogenesis; 2005 Sep; 26(9):1503-12. PubMed ID: 15888491
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of E-cadherin is an essential event in activating beta-catenin/Tcf-dependent transcription and expression of its target genes in Pdcd4 knockdown cells.
Wang Q; Sun ZX; Allgayer H; Yang HS
Oncogene; 2010 Jan; 29(1):128-38. PubMed ID: 19784072
[TBL] [Abstract][Full Text] [Related]
23. Pdcd4 knockdown up-regulates MAP4K1 expression and activation of AP-1 dependent transcription through c-Myc.
Wang Q; Zhang Y; Yang HS
Biochim Biophys Acta; 2012 Oct; 1823(10):1807-14. PubMed ID: 22801218
[TBL] [Abstract][Full Text] [Related]
24. An antisense transcript induced by Wnt/beta-catenin signaling decreases E2F4.
Yochum GS; Cleland R; McWeeney S; Goodman RH
J Biol Chem; 2007 Jan; 282(2):871-8. PubMed ID: 17121828
[TBL] [Abstract][Full Text] [Related]
25. The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling.
Tuupanen S; Turunen M; Lehtonen R; Hallikas O; Vanharanta S; Kivioja T; Björklund M; Wei G; Yan J; Niittymäki I; Mecklin JP; Järvinen H; Ristimäki A; Di-Bernardo M; East P; Carvajal-Carmona L; Houlston RS; Tomlinson I; Palin K; Ukkonen E; Karhu A; Taipale J; Aaltonen LA
Nat Genet; 2009 Aug; 41(8):885-90. PubMed ID: 19561604
[TBL] [Abstract][Full Text] [Related]
26. Myc cooperates with β-catenin to drive gene expression in nephron progenitor cells.
Pan X; Karner CM; Carroll TJ
Development; 2017 Nov; 144(22):4173-4182. PubMed ID: 28993399
[TBL] [Abstract][Full Text] [Related]
27. Upregulation of c-MYC in cis through a large chromatin loop linked to a cancer risk-associated single-nucleotide polymorphism in colorectal cancer cells.
Wright JB; Brown SJ; Cole MD
Mol Cell Biol; 2010 Mar; 30(6):1411-20. PubMed ID: 20065031
[TBL] [Abstract][Full Text] [Related]
28. Keratinocyte transcriptional regulation of the human c-Myc promoter occurs via a novel Lef/Tcf binding element distinct from neoplastic cells.
Kolly C; Zakher A; Strauss C; Suter MM; Müller EJ
FEBS Lett; 2007 May; 581(10):1969-76. PubMed ID: 17466981
[TBL] [Abstract][Full Text] [Related]
29. Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin.
Wang HL; Wang J; Xiao SY; Haydon R; Stoiber D; He TC; Bissonnette M; Hart J
Int J Cancer; 2002 Oct; 101(4):301-10. PubMed ID: 12209953
[TBL] [Abstract][Full Text] [Related]
30. Lymphoid enhancer factor 1 makes cells resistant to transforming growth factor beta-induced repression of c-myc.
Sasaki T; Suzuki H; Yagi K; Furuhashi M; Yao R; Susa S; Noda T; Arai Y; Miyazono K; Kato M
Cancer Res; 2003 Feb; 63(4):801-6. PubMed ID: 12591729
[TBL] [Abstract][Full Text] [Related]
31. Effective treatment of tumors with strong beta-catenin/T-cell factor activity by transcriptionally targeted oncolytic herpes simplex virus vector.
Kuroda T; Rabkin SD; Martuza RL
Cancer Res; 2006 Oct; 66(20):10127-35. PubMed ID: 17047077
[TBL] [Abstract][Full Text] [Related]
32. The human D-glucuronyl C5-epimerase gene is transcriptionally activated through the beta-catenin-TCF4 pathway.
Ghiselli G; Agrawal A
Biochem J; 2005 Sep; 390(Pt 2):493-9. PubMed ID: 15853773
[TBL] [Abstract][Full Text] [Related]
33. Activation of beta-catenin signalling increases StarD7 gene expression in JEG-3 cells.
Rena V; Angeletti S; Panzetta-Dutari G; Genti-Raimondi S
Placenta; 2009 Oct; 30(10):876-83. PubMed ID: 19679347
[TBL] [Abstract][Full Text] [Related]
34. Multiple Wnt/ß-catenin responsive enhancers align with the MYC promoter through long-range chromatin loops.
Yochum GS
PLoS One; 2011 Apr; 6(4):e18966. PubMed ID: 21533051
[TBL] [Abstract][Full Text] [Related]
35. WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells.
Tang Y; Simoneau AR; Liao WX; Yi G; Hope C; Liu F; Li S; Xie J; Holcombe RF; Jurnak FA; Mercola D; Hoang BH; Zi X
Mol Cancer Ther; 2009 Feb; 8(2):458-68. PubMed ID: 19174556
[TBL] [Abstract][Full Text] [Related]
36. Aberrant nuclear localization of EBP50 promotes colorectal carcinogenesis in xenotransplanted mice by modulating TCF-1 and β-catenin interactions.
Lin YY; Hsu YH; Huang HY; Shann YJ; Huang CY; Wei SC; Chen CL; Jou TS
J Clin Invest; 2012 May; 122(5):1881-94. PubMed ID: 22466651
[TBL] [Abstract][Full Text] [Related]
37. TIP49 regulates beta-catenin-mediated neoplastic transformation and T-cell factor target gene induction via effects on chromatin remodeling.
Feng Y; Lee N; Fearon ER
Cancer Res; 2003 Dec; 63(24):8726-34. PubMed ID: 14695187
[TBL] [Abstract][Full Text] [Related]
38. Functional interaction of DNA topoisomerase IIalpha with the beta-catenin and T-cell factor-4 complex.
Huang L; Shitashige M; Satow R; Honda K; Ono M; Yun J; Tomida A; Tsuruo T; Hirohashi S; Yamada T
Gastroenterology; 2007 Nov; 133(5):1569-78. PubMed ID: 17983804
[TBL] [Abstract][Full Text] [Related]
39. Deptor Is a Novel Target of Wnt/β-Catenin/c-Myc and Contributes to Colorectal Cancer Cell Growth.
Wang Q; Zhou Y; Rychahou P; Harris JW; Zaytseva YY; Liu J; Wang C; Weiss HL; Liu C; Lee EY; Evers BM
Cancer Res; 2018 Jun; 78(12):3163-3175. PubMed ID: 29666061
[TBL] [Abstract][Full Text] [Related]
40. Transcription factor Egr1 acts as an upstream regulator of beta-catenin signalling through up-regulation of TCF4 and p300 expression during trans-differentiation of endometrial carcinoma cells.
Saegusa M; Hashimura M; Kuwata T; Hamano M; Watanabe J; Kawaguchi M; Okayasu I
J Pathol; 2008 Dec; 216(4):521-32. PubMed ID: 18798221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]